The audited financial statements and expert analyses paint a different picture of the company than the stories told by Ottobock’s PR department.
Poor corporate governance, persistent losses, rising debt, substantial withdrawals by the owners, and declining innovative strength do not necessarily make for a good equity story for the planned IPO in 2025.
Manager Magazin on Ottobock's third IPO: accounting adjustments inflate EBITDA, valuation at €4.2bn, mounting debt, Näder's KGaA limits shareholder influence.
Welt am Sonntag: Hans Georg Näder faces a German sales tax probe over yacht purchases ahead of Ottobock's IPO; the Russia business raises sanctions risk.
Handelsblatt, 2025: the Ottobock IPO on October 9 faces criticism over its KGaA structure, limited shareholder influence, and Näder's retained control.
Ottobock IPO 2025 FAQ: analysis of key risks including €2.9B leverage, weak earnings, and a P/E above 100× for the prosthetics group backed by Hans Georg Näder.
Ottobock IPO analysis: €2.9B group debt, €161M losses, 11% equity ratio. A critical look at the €4.1B valuation target and Näder's €1.7B holding debt.
Before its October 2025 IPO, Ottobock's patent filings fell from 179 (2018) to 9 (2024), undercutting the innovation narrative and long cost amortisation.
Shareholder representatives criticize Ottobock's planned IPO KGaA structure as a 'no-go': the Näder family keeps full control while investors bear the risk.
Kremlin-sourced report on Ottobock CEO Oliver Jakobi's December 2017 visit with Vladimir Putin, discussing rehabilitation and wheelchair production.